Researchers sought to determine the risk for pulmonary embolism, deep vein thrombosis, and bleeding in patients recovering from COVID-19 infection.
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
Researchers examined the effect of anticoagulation therapy in patients with atrial fibrillation on risk for severe thrombotic events and severe hemorrhage events.
A study was conducted to evaluate the relationship between thromboembolism and bleeding and use of oral anticoagulation therapy in patients with AF and liver disease.
Researchers are seeking to address the psychological impact of patients who have survived VTE.
Researchers sought to determine whether thromboprophylaxis would reduce venous thromboembolism risk in patients with SCD and a central venous access device.
A team of researchers from ACG and CAG released guidelines on periprocedural antithrombotic drug management.
Researchers investigated whether thrombophilia in patients with IBD significantly contributes to developing venous thromboembolic events.
A study sought to determine whether overweight/obesity is a factor in the development of thrombosis in cancer patients with peripherally inserted central catheters.
Investigators compared outcomes of thrombolytic therapy and surgery as first-line treatment for patients with obstructive prosthetic valve thrombosis.